AXON
Price
$590.67
Change
+$13.77 (+2.39%)
Updated
Apr 24 closing price
Capitalization
45.98B
18 days until earnings call
CHRS
Price
$1.01
Change
-$0.10 (-9.01%)
Updated
Apr 24 closing price
Capitalization
117.06M
13 days until earnings call
Ad is loading...

AXON vs CHRS

Header iconAXON vs CHRS Comparison
Open Charts AXON vs CHRSBanner chart's image
Axon Enterprise
Price$590.67
Change+$13.77 (+2.39%)
Volume$493.33K
Capitalization45.98B
Coherus BioSciences
Price$1.01
Change-$0.10 (-9.01%)
Volume$2.1M
Capitalization117.06M
AXON vs CHRS Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. CHRS commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and CHRS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AXON: $590.67 vs. CHRS: $1.01)
Brand notoriety: AXON and CHRS are both not notable
AXON represents the Aerospace & Defense, while CHRS is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 54% vs. CHRS: 109%
Market capitalization -- AXON: $45.98B vs. CHRS: $117.06M
AXON [@Aerospace & Defense] is valued at $45.98B. CHRS’s [@Biotechnology] market capitalization is $117.06M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $210.52B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $16.96B. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whileCHRS’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • CHRS’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than CHRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 6 TA indicator(s) are bullish while CHRS’s TA Score has 5 bullish TA indicator(s).

  • AXON’s TA Score: 6 bullish, 2 bearish.
  • CHRS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AXON is a better buy in the short-term than CHRS.

Price Growth

AXON (@Aerospace & Defense) experienced а +5.57% price change this week, while CHRS (@Biotechnology) price change was -9.82% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +2.04%. For the same industry, the average monthly price growth was -1.28%, and the average quarterly price growth was +16.78%.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

AXON is expected to report earnings on Aug 12, 2025.

CHRS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Aerospace & Defense (+2.04% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($46B) has a higher market cap than CHRS($117M). AXON has higher P/E ratio than CHRS: AXON (123.06) vs CHRS (4.04). AXON YTD gains are higher at: -0.614 vs. CHRS (-26.812). AXON has higher annual earnings (EBITDA): 437M vs. CHRS (37.3M). AXON has more cash in the bank: 986M vs. CHRS (97.7M). CHRS has less debt than AXON: CHRS (270M) vs AXON (722M). AXON has higher revenues than CHRS: AXON (2.08B) vs CHRS (304M).
AXONCHRSAXON / CHRS
Capitalization46B117M39,316%
EBITDA437M37.3M1,172%
Gain YTD-0.614-26.8122%
P/E Ratio123.064.043,046%
Revenue2.08B304M685%
Total Cash986M97.7M1,009%
Total Debt722M270M267%
FUNDAMENTALS RATINGS
AXON vs CHRS: Fundamental Ratings
AXON
CHRS
OUTLOOK RATING
1..100
2319
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
11100
SMR RATING
1..100
47100
PRICE GROWTH RATING
1..100
4046
P/E GROWTH RATING
1..100
5249
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHRS's Valuation (90) in the Biotechnology industry is in the same range as AXON (92). This means that CHRS’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (11) in the Biotechnology industry is significantly better than the same rating for CHRS (100). This means that AXON’s stock grew significantly faster than CHRS’s over the last 12 months.

AXON's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for CHRS (100). This means that AXON’s stock grew somewhat faster than CHRS’s over the last 12 months.

AXON's Price Growth Rating (40) in the Biotechnology industry is in the same range as CHRS (46). This means that AXON’s stock grew similarly to CHRS’s over the last 12 months.

CHRS's P/E Growth Rating (49) in the Biotechnology industry is in the same range as AXON (52). This means that CHRS’s stock grew similarly to AXON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONCHRS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
69%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 22 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOTRF1.240.10
+9.11%
Goliath Resources Ltd.
ASMVY19.410.34
+1.76%
ASMPT LTD.
NPNYY6.660.06
+0.91%
Nippon Yusen Kabushiki Kaisha
TRSSX22.56N/A
N/A
T. Rowe Price Instl Small-Cap Stock
EVSRX22.06N/A
N/A
Allspring Disciplined US Core R6

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
+2.39%
TECH - AXON
61%
Loosely correlated
+1.24%
VCYT - AXON
58%
Loosely correlated
+2.15%
BEAM - AXON
57%
Loosely correlated
+1.51%
SEER - AXON
56%
Loosely correlated
-2.45%
ADPT - AXON
56%
Loosely correlated
+6.91%
More

CHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with ADCT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then ADCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHRS
1D Price
Change %
CHRS100%
-9.01%
ADCT - CHRS
39%
Loosely correlated
+5.43%
ARRY - CHRS
39%
Loosely correlated
+5.31%
AXON - CHRS
38%
Loosely correlated
+2.39%
XENE - CHRS
35%
Loosely correlated
+1.62%
AMRN - CHRS
35%
Loosely correlated
+7.92%
More